Sign in
Taking peopleNo phase

Repeated heart and blood checks after a pulmonary embolism to understand early recovery

Follows adults with pulmonary embolism using repeated tests in the first 48 hours.

Key facts

Who runs it
Sahlgrenska University Hospital
Where
Sweden3 sites in 1 countryChoose a country to see its sites
Trial code
Registry title
Repeated Examinations for Typing Pulmonary Embolism
Status
Recruiting
People taking part
400 people, planned
Started
1 Apr 2026
Expected to end
1 Jan 2032
Type of study
Observational, 2 groups
Record updated
13 October 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults diagnosed with, or followed as out-patients for, a blood clot in the lungs (pulmonary embolism, PE) at Sahlgrenska University Hospital.

Age
18 years and older
Sex
All sexes
Disease stage
Cohort A: intermediate-high risk PE, within 48 hours of diagnosis. Cohort B: PE of any risk class, scheduled for follow-up at Sahlgrenska University Hospital.

Main reasons for not taking part

  • Cohort A: low risk, intermediate-low risk or high risk PE
  • Cohort A: more than 48 hours since PE diagnosis
  • Cohort A: expected to be unable to follow the study plan (for example dementia)
  • Cohort B: not living in the area served by Sahlgrenska University Hospital

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Adult patients (≥ 18 years old) who is diagnosed with, or followed as out-patients for, PE at Sahlgrenska University Hospital
  • Written informed consent

Who cannot take part

  • Expected inability to comply with the protocol (e.g. dementia); Exclusion Criterium from Cohort B:
  • Low risk, intermediate-low risk or high risk PE*
  • >48 hours since PE diagnosis
  • Not geographically belonging to Sahlgrenska University Hospital; *If biomarkers (and/or echocardiography) are not available in hemodynamically stable patients, RV/LV-ratio >1 will be considered as preliminary intermediate-high risk. If biomarkers later fall out negative, the patient will be considered as intermediate-low risk and will be moved to Cohort B

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

PURPOSE

Read full original descriptionShow less

The two related purposes of the RE-TyPE study are:

1. To improve understanding of the early clinical course of intermediate-high risk pulmonary embolism and its association with outcome and 2. To establish a platform for longitudinal follow-up for all pulmonary embolism at Sahlgrenska University Hospital

HYPOTHESES

1. The dynamic pattern of change, evaluated thorough repeated measures of biomarkers, electrocardiography and echocardiography during the first 48 hours after pulmonary embolism, better predicts outcome than static measurements currently used to predict outcome 2. Establishment of a platform for longitudinal follow-up will improve quality of care and outcome for patients with pulmonary embolism at Sahlgrenska University Hospital

The 2 groups in the trial

  • Cohort A

    Intermediate-high risk pulmonary embolism admitted to Sahlgrenska University Hospital - prospective phenotyping thorugh serial investigations day 0, 1, 2 30 and 90.

  • Cohort B

    All risk classes of pulmonary embolism scheduled for follow-up at Sahlgrenska University Hospital - retrospective and prospective phenotyping at day 0, 90 (inclusion) and \>12 months (Cohorts overlap since all patients in Cohort A who geographically belong to Sahlgrenska University Hosptial are also part of Cohort B)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Repeated Examinations for Typing Pulmonary Embolism (RE-TyPE)
Plain-language title
Repeated heart and blood checks after a pulmonary embolism to understand early recoveryGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Record updated
13 October 2026